IBD Highlights
Pancreatic involvement in IBD
Antonio Amodio (1), Armando Gabbrielli (2), Massimo Martinelli (3)
1Cattedra di Gastroenterologia, UOC Gastroenterologia Università di Verona, AOUI Verona2Endoscopia digestiva, UOC Gastroenterologia, AOUI Verona3Dipartimento di Scienze Mediche Traslazionali, Sezione di Pediatria, Università di Napoli “Federico II"
Il punto di vista del gastroenterologo dell’adulto Inflammatory bowel disease (IBD) is characterized by a number of extra- intestinal manifestations, including acute and chronic pancreatitis. Acute pancreatitis in cd can be explained by the presence of biliary stones as a re- sult of ileal disease, anatomic abnormalities of the duodenum, side effects of many medications. Autoimmune pancreatitis is a novel entity associated with IBD, with typical immunological mechanisms. Nonspecific elevations of serum pancreatic enzymes make it difficult to avoid over diagnosis of acute pancreatitis, particularly in Crohn’s disease (CD). Il punto di vista del gastroenterologo pediatra Patients with IBD are at in- creased risk of developing both acute and chronic pancreatitis. There are only limited published data on the inci- dence of acute pancreatitis in pediatric patients with IBD. Although pancreati- tis can be seen in association to drugs assumption, biliary lithiasis, Crohn’s disease duodenal involvement or scle- rosing cholangitis, IBD itself seems to contribute to the pathogenesis. Scarica l’articolo Natural history of pancreatic involvement in paediatric inflammatory bowel disease pubblicato sulla rivista “Digestive and Liver Disease”, numero di Febbraio 2015, descrive la storia naturale dei pazienti con IBD e manifestazioni pancreatiche con un follow-up di 1 anno, e rappresenta una delle prime casistiche pubblicate in età pediatrica. Autori: Massimo Martinelli, Caterina Strisciuglio, Maria Teresa Illiceto, Sabrina Cardile, Graziella Guariso, Silvia Vignola, Marina Aloi, Mario Rocco D’Altilia, Patrizia Alvisi, Silvia Salvatore, Annamaria Staiano, Salvatore Cucchiara, Erasmo Miele, on behalf of IMIBD Group of the Italian Society for Paediatric Gastroenterology, Hepatology and Nutrition